New Elite Feature: Screen & Chart at the same time

Learn More

Research Solutions Reports Third Quarter Fiscal Year 2026 Results

By PR Newswire | May 14, 2026, 4:05 PM

Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA

HENDERSON, Nev., May 14, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal third quarter ended March 31, 2026.

Fiscal Third Quarter 2026 Summary (compared to prior-year quarter)

  • Total revenue of $12.1 million, compared to $12.7 million in the prior-year period.
  • Annual Recurring Revenue ("ARR") up 8.5% to $22.1 million, which includes approximately $15.7 million of B2B recurring revenue and $6.4 million of B2C recurring revenue. 
  • Net income of $860,000 increased 297%, or $0.03 per diluted share, compared to $216,000 or $0.01 per diluted share.
  • Adjusted EBITDA increased 14% to $1.6 million. On a trailing twelve-month ("TTM") basis, the Company has now generated Adjusted EBITDA of $6.0 million, which represents a 12.3% margin.
  • Platform revenue increased 6.6% to $5.2 million. Platform revenue accounted for 43% of total revenue as compared to 38% in the prior-year quarter.
  • Fifteen net new deployments in the quarter and 10% deployment growth over past 12 months.
  • Cash flow from operations was $1.0 million, compared to $2.9 million in the prior-year period, reflecting timing of billings and changes in working capital. On a trailing twelve-month basis, the Company has generated $5.7 million in cash flow from operations.
  • Total gross margin improved 220 basis points to 51.7% on gross profit of $6.3 million.

"We introduced a pair of new AI-based products in recent months, giving Article Galaxy and Scite users the ability to search, review and acquire scientific literature within their existing AI tools. Simplifying the process is critical in an ever-changing research environment, and these tools help us remain an integral partner with researchers. We remain focused on executing over the long term to drive value for our shareholders." said Roy W. Olivier, President and CEO of Research Solutions. "Our third quarter results reflect the improving profitability and growth prospects of our business, even within a softer operating environment. The continued focus across our Platform business is expanding consolidated gross margin and our strategic investment in sales and marketing is helping drive upsells for existing customers and signing larger deals with new logos."

Fiscal Third Quarter 2026 Results

Total revenue was $12.1 million, compared to $12.7 million in the year-ago quarter. Platform revenue growth was more than offset by a decline in lower margins transactions revenue.

Platform subscription revenue for the quarter was $5.2 million, a 6.69% increase from the prior-year period. The increase was primarily due to organic growth in the core B2B platform, due to a mix of new logo generation as well as upsells and cross-selling into existing customers. The quarter ended with annual recurring revenue of $22.1 million, up 8.5% year-over-year (see the Company's definition of annual recurring revenue below).

Transaction revenue was $7.0 million, compared to $7.8 million in the third quarter of fiscal 2025. The decrease was due to lower volume from a known churned customer and a few large customers.  The transaction active customer count for the quarter was 1,346, compared to 1,380 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

Total gross margin improved 220 basis points from the prior-year quarter to 51.7%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business.

Total operating expenses were $5.2 million, compared to $5.7 million in the third quarter of 2025. The decrease was primarily related to reduced general and administrative and stock-based compensation expenses.

Net income in the third quarter was $860,000, or $0.03 per diluted share, compared to net income  of $216,000, or $0.01 per diluted share, in the prior-year quarter. Adjusted EBITDA was $1.6 million, compared to $1.4 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Conference Call

Management will host the conference call, followed by a question-and-answer period.

Date: Thursday, May 14, 2026

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-203-518-9708

Conference ID: RESEARCH

The conference call will be broadcast live and available for replay until June 14, 2026 by dialing  1-412-317-6671 and using the replay ID 11160801, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

Fiscal Third Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter





Quarter Ended March 31,



Nine Months Ended March 31,





2026

2025

Change

% Change



2026

2025

Change

% Change

Revenue:





















Platforms

$       5,160,565

$          4,839,929

$      320,636

6.6 %



$    15,506,250

$     13,770,831

$   1,735,419

12.6 %



Transactions

6,960,996

7,821,434

(860,438)

-11.0 %



20,720,147

22,849,233

(2,129,086)

-9.3 %

Total Revenue

12,121,561

12,661,363

(539,802)

-4.3 %



36,226,397

36,620,064

(393,667)

-1.1 %





















Gross Profit:





















Platforms

4,456,896

4,229,623

227,273

5.4 %



13,569,545

11,993,516

1,576,029

13.1 %



Transactions

1,808,636

2,037,457

(228,821)

-11.2 %



5,098,235

5,860,533

(762,298)

-13.0 %

Total Gross Profit

6,265,532

6,267,080

(1,548)

0.0 %



18,667,780

17,854,049

813,731

4.6 %





















Gross profit as a % of revenue:





















Platforms

86.4 %

87.4 %

-1.0 %





87.5 %

87.1 %

0.4 %





Transactions

26.0 %

26.0 %

-0.1 %





24.6 %

25.6 %

-1.0 %



Total Gross Profit

51.7 %

49.5 %

2.2 %





51.5 %

48.8 %

2.8 %























Operating Expenses:





















Sales and marketing

1,508,897

1,607,678

(98,781)

-6.1 %



4,824,319

4,141,172

683,147

16.5 %



Technology and product development

1,513,074

1,394,936

118,138

8.5 %



4,525,646

4,274,543

251,103

5.9 %



General and administrative

1,625,042

1,845,412

(220,370)

-11.9 %



4,920,996

5,783,789

(862,794)

-14.9 %



Depreciation and amortization

312,402

312,013

389

0.1 %



944,893

930,341

14,552

1.6 %



Stock-based compensation

248,608

594,639

(346,031)

-58.2 %



674,539

1,546,950

(872,411)

-56.4 %



Foreign currency translation loss (gain)

12,529

(44,519)

57,048

-128.1 %



31,385

(119,205)

150,590

126.3 %

Total Operating Expenses

5,220,552

5,710,159

(489,607)

-8.6 %



15,921,778

16,557,590

(635,813)

-3.8 %

Income from operations

1,044,980

556,921

488,059

87.6 %



2,746,002

1,296,459

1,449,544

111.8 %





















Other Income (Expenses):





















Other expenses

(162,607)

(327,042)

164,435

50.3 %



(537,232)

(2,316,404)

1,779,172

76.8 %



Provision for income taxes

(22,168)

(13,410)

(8,758)

-65.3 %



(52,258)

(74,816)

22,558

30.2 %

Total Other Expenses:

(184,775)

(340,452)

155,677

45.7 %



(589,490)

(2,391,220)

1,801,730

75.3 %

Net income (loss)

$          860,205

$             216,469

643,736

297.4 %



$      2,156,512

$     (1,094,761)

3,251,274

297.0 %





















Adjusted EBITDA

$       1,618,519

$          1,419,054

$      199,465

14.1 %



$      4,396,819

$       3,654,545

$       742,274

20.3 %



























Quarter Ended March 31,



Nine Months Ended March 31,





2026

2025

Change

% Change



2026

2025

Change

% Change

Platforms:





















B2B ARR (Annual recurring revenue):





















  Beginning of Period

$     15,318,954

$       12,738,256

$   2,580,697

20.3 %



$    14,197,598

$     12,060,201

$   2,137,397

17.7 %



   Incremental ARR

397,970

735,818

(337,848)

-45.9 %



1,519,326

1,413,873

105,453

7.5 %



  End of Period

$     15,716,923

$       13,474,074

$   2,242,849

16.6 %



$    15,716,923

$     13,474,074

$   2,242,849

16.6 %























Deployments:





















  Beginning of Period

1,232

1,090

142

13.0 %



1,171

1,021

150

14.7 %



   Incremental Deployments

15

43

(28)

-65.1 %



76

112

(36)

-32.1 %



  End of Period

1,247

1,133

114

10.1 %



1,247

1,133

114

10.1 %























ASP (Average sales price):





















  Beginning of Period

$             12,434

$               11,686

$              748

6.4 %



$            12,124

$             11,812

$               312

2.6 %



  End of Period

$             12,604

$               11,892

$              711

6.0 %



$            12,604

$             11,892

$               711

6.0 %

























B2C ARR (Annual recurring revenue):





















  Beginning of Period

$       6,441,416

$          6,371,381

$        70,035

1.1 %



$      6,721,356

$       5,363,129

$   1,358,227

25.3 %



   Incremental ARR

(80,748)

506,545

(587,293)

NM



(360,688)

1,514,797

(1,875,485)

-123.8 %



  End of Period

$       6,360,668

$          6,877,926

$    (517,258)

-7.5 %



$      6,360,668

$       6,877,926

$     (517,258)

-7.5 %

























Total ARR (Annualized recurring revenue):

$     22,077,591

$       20,352,000

$   1,725,591

8.5 %



$    22,077,591

$     20,352,000

$   1,725,591

8.5 %























Transaction Customers:





















Corporate customers

1,009

1,060

(51)

-4.8 %



995

1,062

(67)

-6.3 %



Academic customers

337

320

17

5.3 %



336

323

13

4.0 %



Total customers

1,346

1,380

(34)

-2.5 %



1,331

1,385

(54)

-3.9 %

Active Customer Accounts, Transactions and Annual Recurring Revenue

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period.  For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

Use of Non-GAAP Measure – Adjusted EBITDA

Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):





Quarter Ended March 31,



Nine Months Ended March 31,





2026

2025

Change

% Change



2026

2025

Change

% Change























Net Income (loss)

$          860,205

$             216,469

$      643,736

-297.4 %



$      2,156,512

$     (1,094,761)

$   3,251,274

297.0 %

 Add (deduct):





















Other (income) expense

162,607

327,042

(164,435)

NM



537,232

2,316,404

(1,779,172)

-76.8 %



Foreign currency translation loss (gain)

12,529

(44,519)

57,048

-128.1 %



31,385

(119,205)

150,590

126.3 %



Provision for income taxes

22,168

13,410

8,758

65.3 %



52,258

74,816

(22,558)

-30.2 %



Depreciation and amortization

312,402

312,013

389

0.1 %



944,893

930,341

14,552

1.6 %



Stock-based compensation

248,608

594,639

(346,031)

-58.2 %



674,539

1,546,950

(872,411)

-56.4 %

 Adjusted EBITDA

$       1,618,519

$          1,419,054

$      199,465

14.1 %



$      4,396,819

$       3,654,545

$       742,275

20.3 %

About Research Solutions

Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)









March 31,



June 30,







2026



2025



Assets















Current assets:















Cash and cash equivalents



$

12,050,396



$

12,227,312



Accounts receivable, net of allowance of $94,234 and $182,324, respectively





7,601,477





7,191,234



Prepaid expenses and other current assets





893,176





580,257



Prepaid royalties





132,426





925



Total current assets





20,677,475





19,999,728



















Non-current assets:















Property and equipment, net of accumulated depreciation of $1,003,915

and $964,883, respectively





57,859





60,769



Intangible assets, net of accumulated amortization of $3,648,497 and $2,736,773,

respectively





8,836,604





9,686,241



Goodwill





16,372,979





16,372,979



Deposits and other assets





998





957



Total assets



$

45,945,915



$

46,120,674



















Liabilities and Stockholders' Equity















Current liabilities:















Accounts payable and accrued expenses



$

6,687,477



$

7,443,757



Deferred revenue, current portion





11,105,272





10,702,120



Contingent earnout liability, current portion





7,310,763





7,363,152



Total current liabilities





25,103,512





25,509,029



















Non-current liabilities:















Deferred revenue, long-term portion





56,508







Contingent earnout liability, long-term portion





1,726,046





6,683,488



Total liabilities





26,886,066





32,192,517



















Commitments and contingencies































Stockholders' equity:















Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued

and outstanding











Common stock; $0.001 par value; 100,000,000 shares authorized; 33,154,273 and

32,479,993 shares issued and outstanding, respectively





33,154





32,480



Additional paid-in capital





42,023,679





39,059,557



Accumulated deficit





(22,887,181)





(25,043,693)



Accumulated other comprehensive loss





(109,803)





(120,187)



Total stockholders' equity





19,059,849





13,928,157



Total liabilities and stockholders' equity



$

45,945,915



$

46,120,674





See notes to condensed consolidated financial statements



 

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Unaudited)









Three Months Ended



Nine Months Ended







March 31,



March 31,







2026



2025



2026



2025































Revenue:



























Platforms



$

5,160,565



$

4,839,929



$

15,506,250



$

13,770,831



Transactions





6,960,996





7,821,434





20,720,147





22,849,233



Total revenue





12,121,561





12,661,363





36,226,397





36,620,064































Cost of revenue:



























Platforms





703,669





610,306





1,936,705





1,777,315



Transactions





5,152,360





5,783,977





15,621,912





16,988,700



Total cost of revenue





5,856,029





6,394,283





17,558,617





18,766,015



Gross profit





6,265,532





6,267,080





18,667,780





17,854,049































Operating expenses:



























Selling, general and administrative





4,908,149





5,398,145





14,976,885





15,627,248



Depreciation and amortization





312,402





312,013





944,893





930,341



Total operating expenses





5,220,551





5,710,158





15,921,778





16,557,589































Income from operations





1,044,981





556,922





2,746,002





1,296,460































Other income





83,919





78,868





305,897





496,392



Accreted interest expense





(246,526)









(843,129)







Change in fair value of contingent earnout liability









(405,910)









(2,812,796)































Income (loss) before provision for income taxes





882,374





229,880





2,208,770





(1,019,944)



Provision for income taxes





(22,168)





(13,410)





(52,258)





(74,816)































Net income (loss)





860,206





216,470





2,156,512





(1,094,760)































Other comprehensive income (loss):



























Foreign currency translation





3,558





(3,324)





10,384





(6,855)



Comprehensive income (loss)



$

863,764



$

213,146



$

2,166,896



$

(1,101,615)































Basic income (loss) per common share:



























Net income (loss) per share



$

0.03



$

0.01



$

0.07



$

(0.04)



Weighted average common shares outstanding





31,999,813





31,033,022





31,619,417





30,597,410































Diluted income (loss) per common share:



























Net income (loss) per share



$

0.03



$

0.01



$

0.07



$

(0.04)



Weighted average common shares outstanding





32,435,370





32,139,935





32,154,594





30,597,410





See notes to condensed consolidated financial statements



 

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)







Nine Months Ended







March 31,







2026



2025



















Cash flow from operating activities:















Net income (loss)



$

2,156,512



$

(1,094,760)



Adjustment to reconcile net income (loss) to net cash provided by operating activities:















Depreciation and amortization





944,893





930,341



Stock options expense





239,818





146,751



Restricted common stock expense





434,721





1,400,199



Accreted interest expense





843,129







Adjustment to contingent earnout liability









2,812,796



Changes in operating assets and liabilities:















Accounts receivable





(410,243)





(754,258)



Prepaid expenses and other current assets





(312,919)





17,826



Prepaid royalties





(131,501)





311,938



Accounts payable and accrued expenses





(724,921)





(338,502)



Deferred revenue





459,660





1,331,920



Net cash provided by operating activities





3,499,149





4,764,251



















Cash flow from investing activities:















Purchase of property and equipment





(28,609)





(11,571)



Net cash used in investing activities





(28,609)





(11,571)



















Cash flow from financing activities:















Proceeds from the exercise of stock options





157,500







Common stock repurchase





(47,385)





(908,393)



Payment of contingent acquisition consideration - Scite andFIZ





(3,766,263)





(91,174)



Net cash used in financing activities





(3,656,148)





(999,567)



















Effect of exchange rate changes





8,692





(1,137)



Net increase (decrease) in cash and cash equivalents





(176,916)





3,751,976



Cash and cash equivalents, beginning of period





12,227,312





6,100,031



Cash and cash equivalents, end of period



$

12,050,396



$

9,852,007



















Supplemental disclosures of cash flow information:















Cash paid for income taxes



$

52,258



$

74,816



















Non-cash investing and financing activities:















Contingent consideration accrual on asset acquisition



$



$

29,394



Common stock issued for Sciteearnout payment



$

2,180,142



$





See notes to condensed consolidated financial statements

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-third-quarter-fiscal-year-2026-results-302772825.html

SOURCE Research Solutions, Inc.

Mentioned In This Article

Latest News

May-14
May-06
Apr-29
Apr-07
Mar-12
Mar-02
Feb-26
Feb-20
Feb-15
Feb-13
Feb-12
Feb-12
Feb-12
Feb-04
Feb-03